230 related articles for article (PubMed ID: 25733770)
1. Stem cell-derived nodal-like cardiomyocytes as a novel pharmacologic tool: insights from sinoatrial node development and function.
Barbuti A; Robinson RB
Pharmacol Rev; 2015; 67(2):368-88. PubMed ID: 25733770
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived CD166+ precursors develop into fully functional sinoatrial-like cells.
Scavone A; Capilupo D; Mazzocchi N; Crespi A; Zoia S; Campostrini G; Bucchi A; Milanesi R; Baruscotti M; Benedetti S; Antonini S; Messina G; DiFrancesco D; Barbuti A
Circ Res; 2013 Aug; 113(4):389-98. PubMed ID: 23753573
[TBL] [Abstract][Full Text] [Related]
3. Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker.
Protze SI; Liu J; Nussinovitch U; Ohana L; Backx PH; Gepstein L; Keller GM
Nat Biotechnol; 2017 Jan; 35(1):56-68. PubMed ID: 27941801
[TBL] [Abstract][Full Text] [Related]
4. Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells.
Geuss LR; Suggs LJ
Biotechnol Prog; 2013; 29(5):1089-96. PubMed ID: 23956196
[TBL] [Abstract][Full Text] [Related]
5. Embryological development of pacemaker hierarchy and membrane currents related to the function of the adult sinus node: implications for autonomic modulation of biopacemakers.
Opthof T
Med Biol Eng Comput; 2007 Feb; 45(2):119-32. PubMed ID: 17203321
[TBL] [Abstract][Full Text] [Related]
6. Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells.
Schweizer PA; Darche FF; Ullrich ND; Geschwill P; Greber B; Rivinius R; Seyler C; Müller-Decker K; Draguhn A; Utikal J; Koenen M; Katus HA; Thomas D
Stem Cell Res Ther; 2017 Oct; 8(1):229. PubMed ID: 29037217
[TBL] [Abstract][Full Text] [Related]
7. Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin.
Wiese C; Nikolova T; Zahanich I; Sulzbacher S; Fuchs J; Yamanaka S; Graf E; Ravens U; Boheler KR; Wobus AM
Int J Cardiol; 2011 Feb; 147(1):95-111. PubMed ID: 19775764
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior.
Mandel Y; Weissman A; Schick R; Barad L; Novak A; Meiry G; Goldberg S; Lorber A; Rosen MR; Itskovitz-Eldor J; Binah O
Circulation; 2012 Feb; 125(7):883-93. PubMed ID: 22261196
[TBL] [Abstract][Full Text] [Related]
9. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.
Capi O; Gepstein L
J Control Release; 2006 Nov; 116(2):211-8. PubMed ID: 17005287
[TBL] [Abstract][Full Text] [Related]
10. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
[TBL] [Abstract][Full Text] [Related]
11. Genetic isolation of stem cell-derived pacemaker-nodal cardiac myocytes.
Hashem SI; Claycomb WC
Mol Cell Biochem; 2013 Nov; 383(1-2):161-71. PubMed ID: 23877224
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells.
Zhu WZ; Xie Y; Moyes KW; Gold JD; Askari B; Laflamme MA
Circ Res; 2010 Sep; 107(6):776-86. PubMed ID: 20671236
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of mouse embryonic stem cells into cardiomyocytes via the hanging-drop and mass culture methods.
Fuegemann CJ; Samraj AK; Walsh S; Fleischmann BK; Jovinge S; Breitbach M
Curr Protoc Stem Cell Biol; 2010 Dec; Chapter 1():Unit 1F.11. PubMed ID: 21125557
[TBL] [Abstract][Full Text] [Related]
14. Mesoangioblasts from ventricular vessels can differentiate in vitro into cardiac myocytes with sinoatrial-like properties.
Barbuti A; Galvez BG; Crespi A; Scavone A; Baruscotti M; Brioschi C; Cossu G; DiFrancesco D
J Mol Cell Cardiol; 2010 Feb; 48(2):415-23. PubMed ID: 19837079
[TBL] [Abstract][Full Text] [Related]
15. Generation of cardiac pacemaker cells by programming and differentiation.
Husse B; Franz WM
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1948-52. PubMed ID: 26681531
[TBL] [Abstract][Full Text] [Related]
16. [Review of basic studies about the cardiac stem cell and regenerative medicine].
Tamura Y; Fukuda K
Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
[TBL] [Abstract][Full Text] [Related]
17. SHOX2 overexpression favors differentiation of embryonic stem cells into cardiac pacemaker cells, improving biological pacing ability.
Ionta V; Liang W; Kim EH; Rafie R; Giacomello A; Marbán E; Cho HC
Stem Cell Reports; 2015 Jan; 4(1):129-142. PubMed ID: 25533636
[TBL] [Abstract][Full Text] [Related]
18. ES and iPS cell research for cardiovascular regeneration.
Yamashita JK
Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of spontaneous pacing: sinoatrial nodal cells, neonatal cardiomyocytes, and human stem cell derived cardiomyocytes.
Morad M; Zhang XH
Can J Physiol Pharmacol; 2017 Oct; 95(10):1100-1107. PubMed ID: 28350969
[TBL] [Abstract][Full Text] [Related]
20. [Role of over-expression of TBX3 and TBX18 in the enrichment and differentiation of human induced pluripotent stem cells into sinoatrial node-like cells].
Liu F; Fang Y; Xiong Q; Luo L; Zhou R; Liao B
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2019 Apr; 33(4):497-506. PubMed ID: 30983202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
